News - MedTech & Diagnostics
Private health insurers take Australians for April Fools

MedTech News: Private health insurance premiums have today increased by over 2.7%, the second increase in six months, with some Australian families being forced to face premium increases as high as 5.47% – a whopping six-times inflation.
Corporate health insurers are treating Australians like April Fools if they truly believe struggling families will cop a second hike in their premiums in the span of just six months, despite Australian Prudential Regulation Authority (APRA) data showing that in the three months to December 2020, insurers profits increased by 205.4%.
Despite raking in mega-covid-profits, the corporate health insurer’s lobby group, Private Healthcare Australia (PHA), claims “medical device prices are the largest driver of the 1 April premium increases”. Unfortunately for PHA, those claims do not add up given medical device costs make up less than 10% of the benefits insurers are required to pay, as well as the fact the total cost of devices for insurers has decreased by 3.95% in 2020.
Medical Technology Association of Australia CEO, Ian Burgess, said the scare campaign by corporate health insurers is being used to distract from their unjustifiable back-to-back premium increases and to push the Federal Government into radical, so called, reforms that would abolish patient access and surgeon choice guaranteed by the Prostheses List.
“It’s hard to fathom how insurers can increase premiums on Australians by more than six-times inflation, rake in mega-profits of 205.4% in the last quarter, and still claim they’re doing it tough,” Mr Burgess said.
“Enough is enough, it’s time for corporate health insurers and their lobbyist at PHA to stop playing politics and come to the table with MTAA and work through real and meaningful solutions to ensure Australians have access to the life-saving and life-changing medical devices, chosen by their surgeons and not insurers.”
MTAA has joined with the Australian Medical Association (AMA), Australian Private Hospitals Association (APHA) and Consumer Health Forum (CHF) to issue a joint statement opposing the changes being pushed by corporate health insurers that would see the patient access and surgeon choice guarantee of the Prostheses List abolished and replaced with a managed care system where insurers would be able to influence what device a patient would or would not get access to.
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More